http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101734093-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-644 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-644 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate | 2016-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101734093-B1 |
| titleOfInvention | A pharmaceutical composition for preventing and treating inflammatory disease containing the purified bee venom which was reduced allergen, as a active ingredient |
| abstract | The present invention relates to a method for preparing an anti-allergic tablet bee venom and a pharmaceutical composition for preventing and treating inflammatory diseases containing the purified bee venom as an active ingredient, wherein the purified bee venom is selected from the group consisting of phospholipase A2 PLA2) and histamine were eliminated and the side effects (pain, edema, itching, rashes, etc.) were reduced, and the content of melittin, an effective substance, was increased. As a result, The tablet bee venom can be used as a pharmaceutical composition for the prevention and treatment of inflammatory diseases. |
| priorityDate | 2016-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 234.